Likarda
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Missouri, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10330 Hickman Mills Dr Ste B, Kansas Cit...Phone Number
(816) 605-6440Website
www.likarda.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Likarda
Likarda specializes in advanced drug delivery solutions, providing enabling technologies for small molecules, biologics, and cell therapies through their proprietary Core-Shell Spherification (CSS) encapsulation platform. They partner with biotech, pharmaceutical, and research organizations to address complex therapeutic challenges, ensuring precise control over drug release and enhancing treatment outcomes. Their offerings include customized hydrogel platforms, cryopreservation solutions, and cell therapy systems designed to protect and sustain the function of living cells. Likarda is committed to innovation and scalability, investing in new manufacturing capabilities to meet the growing demand for their hydrogel delivery technologies.Explore more
Likarda Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Likarda your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Likarda, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Likarda has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Likarda recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Likarda is spiking on competitors!
Click to see if Likarda had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Likarda has new funding data
Product Launch: Get notified when Likarda launches new products
Congratulate Masked Content for being promoted to Masked Content at Likarda
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Likarda
Compare insights from companies similar to Likarda, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Likarda is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Likarda is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Likarda.
Likarda financials insights
Gather financial insights about Likarda, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$4M
2021
Debt
$144K
Likarda Tech Stack
A closer look at the technologies used by Likarda
Most Recent Scoops
Event
Person-Based
Events, Search, Medical Research
New Hire
Executive Move
Executive Moves, New Hire
Project
Spending/Investment
New Hire
Executive Move
Partnership
Research & Development
Likarda News & Media
Likarda Appoints Shelly Adams Chief Commercial Officer - Contract Pharma
She has over 25 years of global sales and management experience and over 15 years of marketing experience.Oral Biolife Announces Manufacturing Partnership with Likarda
BETHLEHEM , PA, USA, November 17, 2023 /EINPresswire.com/ -- Oral Biolife (OBL), a biotechnology company headquartered in Bethlehem, PA, committed to the discovery and development of pioneering therapies for the treatment of periodontal disease for …Likarda Announces Core Shell Spherification for Large Molecule Biologics and Welcomes New CEO, Dr. Stella Vnook
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Likarda, LLC, a pioneering cell therapy company, is at the forefront of creating advanced delivery systems that enhance the efficacy of cell therapies. Central to their innovative approach is the Core-Shell Spherification® (CSS®) platform technology, designed to significantly elevate treatment outcomes. In a significant move for the biologics industry, Likarda is proud to announce two major developments: the expansion of its Core Shell Spherification (CSS) tecLikarda and eQcell Announce License Option Agreement
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Likarda, LLC, a cell therapy company developing innovative delivery systems announced a license option agreement today with eQcell.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Likarda
Sign Up For FreeTo access detailed company insights
Likarda specializes in advanced drug delivery solutions, providing enabling technologies for small molecules, biologics, and cell therapies through their proprietary Core-Shell Spherification (CSS) encapsulation platform. They partner with biotech, pharmaceutical, and research organizations to address complex therapeutic challenges, ensuring precis... Read More
